What are the medications known to have hepatotoxic effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comprehensive List of Hepatotoxic Medications

Medications with known hepatotoxic potential should be carefully monitored, as drug-induced liver injury can lead to significant morbidity and mortality, with some agents requiring permanent discontinuation after severe reactions. 1

First-Line Antitubercular Drugs

  • Isoniazid (INH): Major hepatotoxin that can cause severe liver injury
  • Pyrazinamide (PZA): Most hepatotoxic among first-line TB agents
  • Rifampin: Less hepatotoxic alone but enhances isoniazid hepatotoxicity
  • Rifampin-Pyrazinamide (RZ) combination: Associated with severe liver injury and death (hospitalization rate 3.0 per 1,000 treatment initiations; mortality rate 0.9 per 1,000) 2

NSAIDs

  • Diclofenac: Can cause marked elevations in transaminases (>8 times ULN in about 1% of patients) 3
  • Bromfenac: Withdrawn due to hepatotoxicity
  • COX-2 inhibitors: Both preferential and selective inhibitors have hepatotoxic potential 4

Anticonvulsants

  • Carbamazepine: Associated with hepatocellular tumors in animal studies; can cause granulomatous hepatitis 5, 6
  • Valproic acid: Can cause severe hepatotoxicity, especially in patients with risk factors 4
  • Phenytoin: Known hepatotoxin 4

Antimicrobials

  • Amoxicillin-clavulanic acid: One of the most frequently implicated causes of drug-induced liver injury worldwide 7
  • Macrolide antibiotics (Clarithromycin, Azithromycin): Can cause hepatitis 1

Antiretroviral Medications

  • Nevirapine: Can cause severe clinical hepatitis in up to 12% of female patients 2, 1
  • Lopinavir-ritonavir: ALT may increase to >5× ULN in 5% of patients 1
  • Protease inhibitors: Associated with liver enzyme abnormalities that can occur at any time during treatment 2

Antimalarial Medications

  • Chloroquine and Hydroxychloroquine: Both have likelihood score D (possible rare cause of clinically apparent liver injury) 2, 1

Antidiabetic Agents

  • Acarbose, Gliclazide, Metformin: Implicated in causing liver injury 4
  • Troglitazone: Withdrawn due to hepatotoxicity 4

Lipid-Lowering Agents

  • Statins: Can cause transaminase elevations in approximately 1% of patients 1
  • Niacin: Can cause hepatitis and elevations in liver enzymes 1
  • Lomitapide: May cause elevations in liver transaminases 1

Antihypertensive Agents

  • Methyldopa: Known hepatotoxin (though rarely prescribed now) 4
  • Angiotensin receptor blockers and ACE inhibitors: Increasingly reported to cause liver injury 4

Psychotropic Drugs

  • Clozapine: Requires regular monitoring of liver function tests 1
  • Selective serotonin reuptake inhibitors (SSRIs): Associated with liver injury 4

Immunomodulators

  • Methotrexate: Requires liver biopsy monitoring at high cumulative doses 1
  • Immune checkpoint inhibitors: Can cause immune-mediated hepatitis 1

Antiasthmatic Medications

  • Montelukast and Zafirlukast: Can cause reversible hepatitis and rarely irreversible hepatic failure 1
  • Zileuton: Can cause elevation of liver enzymes 1

Antiviral Medications

  • Remdesivir: Can cause mild ALT elevation to >2× ULN 1

Over-the-Counter Medications

  • Acetaminophen: Major cause of drug-induced liver injury 8
  • Diphenhydramine: Can rarely cause severe liver injury 1

Monitoring Recommendations

For patients taking hepatotoxic medications:

  1. Baseline liver function tests before starting therapy

  2. Regular monitoring schedule:

    • For anti-TB drugs: Every 2 weeks for first 2 months, then monthly 9
    • For immune checkpoint inhibitors: Before each infusion 1
    • For clozapine: Monthly for first 6 months, then every 1-3 months 1
  3. Action based on liver enzyme elevations:

    • <2× ULN: Continue medication, repeat testing in 2-4 weeks
    • ≥2× but <3× ULN: Consider dose reduction
    • ≥3× but <5× ULN: Consider temporary discontinuation
    • 5× ULN: Discontinue medication and consider hepatology consultation 1

High-Risk Patients

Patients with the following factors require closer monitoring:

  • Pre-existing liver disease
  • Alcohol consumption
  • Obesity
  • Diabetes
  • Advanced age
  • Concomitant use of multiple hepatotoxic drugs 1

Patient Education

Patients taking hepatotoxic medications should be instructed to:

  • Avoid alcohol consumption
  • Avoid over-the-counter medications containing acetaminophen
  • Report symptoms like fatigue, nausea, right upper abdominal discomfort, dark urine, or jaundice immediately 1

This comprehensive list highlights the most common hepatotoxic medications across various drug classes, with monitoring recommendations to minimize the risk of serious liver injury.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.